Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HCW Biologics (HCWB) Other Non-Current Liabilities (2022 - 2025)

Historic Other Non-Current Liabilities for HCW Biologics (HCWB) over the last 3 years, with Q3 2025 value amounting to $692531.0.

  • HCW Biologics' Other Non-Current Liabilities changed N/A to $692531.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $692531.0, marking a year-over-year change of. This contributed to the annual value of $68500.0 for FY2023, which is 37985.99% up from last year.
  • Per HCW Biologics' latest filing, its Other Non-Current Liabilities stood at $692531.0 for Q3 2025.
  • HCW Biologics' 5-year Other Non-Current Liabilities high stood at $1.7 million for Q2 2025, and its period low was $7476.0 during Q1 2023.
  • Moreover, its 3-year median value for Other Non-Current Liabilities was $68500.0 (2023), whereas its average is $319984.2.
  • Examining YoY changes over the last 5 years, HCW Biologics' Other Non-Current Liabilities showed a top increase of 37985.99% in 2023 and a maximum decrease of 9464.46% in 2023.
  • Over the past 3 years, HCW Biologics' Other Non-Current Liabilities (Quarter) stood at $14275.0 in 2022, then soared by 379.86% to $68500.0 in 2023, then skyrocketed by 910.99% to $692531.0 in 2025.
  • Its last three reported values are $692531.0 in Q3 2025, $1.7 million for Q2 2025, and $54000.0 during Q1 2025.